Literature DB >> 14739309

Value of transcatheter arterial embolization with coils and n-butyl cyanoacrylate for long-term hepatic arterial infusion chemotherapy.

Takuji Yamagami1, Takeharu Kato, Shigeharu Iida, Osamu Tanaka, Tsunehiko Nishimura.   

Abstract

PURPOSE: To assess the value of transcatheter arterial embolization (TAE) of splanchnic arterial branches to allow continuous application of repeat hepatic arterial infusion chemotherapy (HAIC).
MATERIALS AND METHODS: In 128 patients with unresectable advanced liver cancer, percutaneous implantation of a port catheter system and TAE of splanchnic arteries with coils and/or n-butyl cyanoacrylate (NBCA) were performed. Parameters included (a) methods selected for catheter placement; (b) embolic materials used (coils and/or NBCA, number of coils, administration rate of NBCA-iodized oil) for TAE of splanchnic arteries, details of embolized arteries, and frequency of recanalization; (c) ability to prevent gastrointestinal symptoms by avoiding inflow of anticancer drugs into extrahepatic adjacent organs and to maintain distribution of contrast agents in liver, as well as management of difficulties encountered; (d) complications related to catheter system implantation or to long-term HAIC and management of such complications; and (e) final success in performing scheduled HAIC while maintaining distribution over liver via a single route without gastrointestinal symptoms caused by inflow of anticancer drugs. Fisher exact test was used to compare recanalization rate between coil-embolized and NBCA- or NBCA-coil-embolized arteries, and frequency of heterogeneously poor distribution was compared between patients with single and those with multiple hepatic arteries.
RESULTS: Embolization was successful during first catheterization in 326 arteries and during follow-up in 10. In 119 (93.0%) of 128 patients, repeat HAIC was effective until death or the time of this writing (observation period, 2-47 months). HAIC was continued in two patients, although anticancer drugs did not distribute to all liver tumors. Arteries once embolized with coils alone spontaneously recanalized at a significantly higher rate than those with NBCA (eight of 192 vs one of 144, P =.048). Rate of heterogeneously poor distribution was significantly higher in those with two or more hepatic arteries than in those with one (seven of 17 vs nine of 111, P =.001).
CONCLUSION: TAE for various splanchnic organs is useful for efficient performance of long-term HAIC. Copyright RSNA, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14739309     DOI: 10.1148/radiol.2303021564

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  Hepatic arterial infusion chemotherapy with a coaxial reservoir system using a non-braided spiral tip microcatheter.

Authors:  Masamichi Koganemaru; Toshi Abe; Ryoji Iwamoto; Masaaki Nonoshita; Seigo Yoshida; Daiji Uchiyama; Naofumi Hayabuchi
Journal:  Jpn J Radiol       Date:  2011-12-02       Impact factor: 2.374

2.  A simplified technique of percutaneous hepatic artery port-catheter insertion for the treatment of advanced hepatocellular carcinoma with portal vein invasion.

Authors:  Sun Young Choi; Ah Hyun Kim; Kyung Ah Kim; Jong Yun Won; Do Yun Lee; Kwang-Hun Lee
Journal:  Korean J Radiol       Date:  2010-10-29       Impact factor: 3.500

3.  Regional thermochemotherapy versus hepatic arterial infusion chemotherapy for palliative treatment of advanced hilar cholangiocarcinoma: a retrospective controlled study.

Authors:  Yaoting Chen; Huiqing Li; Xiongying Jiang; Dong Chen; Jiayan Ni; Hongliang Sun; Jianghong Luo; Herui Yao; Linfeng Xu
Journal:  Eur Radiol       Date:  2016-01-28       Impact factor: 5.315

4.  Intermittent transcatheter therapy through a new indwelling catheter system for patients with hepatocellular carcinoma.

Authors:  Osamu Itano; Satoshi Itano; Hiroaki Nagamatsu; Rina Tsutsui; Akihiro Deguchi; Masanori Inoue; Seishi Nakatsuka
Journal:  Jpn J Radiol       Date:  2014-09-27       Impact factor: 2.374

5.  Dysfunction of a port-catheter system percutaneously implanted for hepatic arterial infusion chemotherapy due to a fibrin sheath.

Authors:  Takuji Yamagami; Tomohiro Matsumoto; Rika Yoshimatsu; Tsunehiko Nishimura
Journal:  Clin J Gastroenterol       Date:  2008-12-25

6.  Embolisation of the right gastric artery in patients undergoing hepatic arterial infusion chemotherapy using two possible approach routes.

Authors:  T Yamagami; K Terayama; R Yoshimatsu; T Matsumoto; H Miura; T Nishimura
Journal:  Br J Radiol       Date:  2010-05-04       Impact factor: 3.039

7.  Clinical efficacy and value of redistributed subclavian arterial infusion chemotherapy for locally advanced breast cancer.

Authors:  Hiroshi Shimamoto; Kenji Takizawa; Yukihisa Ogawa; Misako Yoshimatsu; Kunihiro Yagihashi; Hiroko Okazaki; Yoshihide Kanemaki; Yasuo Nakajima; Tomohiko Ohta; Haruki Ogata; Mamoru Fukuda
Journal:  Jpn J Radiol       Date:  2011-05-24       Impact factor: 2.374

8.  Value of Micronester coils in port-catheter implantation for continuous hepatic arterial infusion chemotherapy with fixed catheter tip method.

Authors:  Takuji Yamagami; Takeharu Kato; Tatsuya Hirota; Rika Yoshimatsu; Tomohiro Matsumoto; Robert I White; Tsunehiko Nishimura
Journal:  Eur Radiol       Date:  2007-07-10       Impact factor: 5.315

9.  Guidelines for the use of NBCA in vascular embolization devised by the Committee of Practice Guidelines of the Japanese Society of Interventional Radiology (CGJSIR), 2012 edition.

Authors:  Yoshito Takeuchi; Hiroyuki Morishita; Yozo Sato; Shingo Hamaguchi; Noriaki Sakamoto; Hiroyuki Tokue; Takafumi Yonemitsu; Kenji Murakami; Hiroyasu Fujiwara; Keitaro Sofue; Toshi Abe; Hideyuki Higashihara; Yasuo Nakajima; Morio Sato
Journal:  Jpn J Radiol       Date:  2014-06-03       Impact factor: 2.374

10.  Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma.

Authors:  T Susanna Meijer; Lioe-Fee de Geus-Oei; Christian H Martini; Fred G J Tijl; M Elske Sitsen; Arian R van Erkel; Rutger W van der Meer; Ellen Kapiteijn; Alexander L Vahrmeijer; Mark C Burgmans
Journal:  Diagn Interv Radiol       Date:  2019-11       Impact factor: 2.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.